Julio Delgado Selected Research

Multiple Myeloma

11/2021	EMA Review of Isatuximab in Combination with Pomalidomide and Dexamethasone for the Treatment of Adult Patients with Relapsed and Refractory Multiple Myeloma.
1/2021	EMA Review of Belantamab Mafodotin (Blenrep) for the Treatment of Adult Patients with Relapsed/Refractory Multiple Myeloma.
5/2016	Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.
2/2006	The P2X7 receptor gene polymorphism 1513 A-->C has no effect on clinical prognostic markers and survival in multiple myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julio Delgado Research Topics

Disease

44	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 02/2022 - 11/2003
24	Neoplasms (Cancer) 02/2022 - 03/2004
8	Disease Progression 01/2021 - 09/2002
6	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 07/2010
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2021
5	Diarrhea 08/2021 - 07/2014
5	Asthma (Bronchial Asthma) 01/2021 - 11/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 01/2017
4	Multiple Myeloma 11/2021 - 02/2006
4	Fever (Fevers) 08/2021 - 07/2014
4	Nausea 07/2021 - 07/2014
4	Neutropenia 01/2021 - 01/2012
4	Infections 01/2021 - 09/2006
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2012 - 11/2008
3	Anemia 08/2021 - 12/2018
3	Cough 08/2021 - 07/2014
3	Hairy Cell Leukemia 01/2021 - 03/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 02/2002
3	Leukemia 11/2019 - 03/2004
3	Trisomy (Trisomies) 01/2019 - 01/2016
2	Lymphadenopathy 01/2022 - 01/2017
2	Lymphoma (Lymphomas) 01/2022 - 07/2010
2	Headache (Headaches) 08/2021 - 01/2021
2	Arthralgia (Joint Pain) 08/2021 - 07/2021
2	Fatigue 08/2021 - 07/2014
2	Pain (Aches) 08/2021 - 07/2021
2	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2017
2	Hypersensitivity (Allergy) 01/2021 - 03/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2019 - 07/2014
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2016 - 12/2002
2	Hemophilia A (Haemophilia) 04/2003 - 09/2002
1	Cytopenia 01/2022
1	Back Pain (Backache) 08/2021
1	beta-Thalassemia (Cooley's Anemia) 08/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2021
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2021
1	Cytokine Release Syndrome 01/2021

Drug/Important Bio-Agent (IBA)

12	Biological ProductsIBA 01/2022 - 10/2014
8	fludarabineIBA 01/2021 - 01/2006
8	Rituximab (Mabthera)FDA Link 01/2020 - 09/2009
6	ibrutinibIBA 12/2021 - 07/2014
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2004
5	Chimeric Antigen ReceptorsIBA 01/2022 - 03/2019
5	Monoclonal AntibodiesIBA 12/2021 - 02/2002
4	idelalisibIBA 02/2022 - 01/2017
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2016
4	AllergensIBA 01/2021 - 08/2013
4	Bendamustine Hydrochloride FDA Link 11/2019 - 05/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 09/2009
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
3	AntigensIBA 01/2021 - 01/2019
3	Immunoglobulins (Immunoglobulin)IBA 01/2020 - 09/2006
3	ofatumumab FDA Link 01/2020 - 07/2014
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2012 - 01/2009
3	Melphalan (Alkeran)FDA LinkGeneric 07/2010 - 02/2006
2	immunotoxin HA22IBA 01/2021 - 01/2018
2	duvelisibIBA 01/2020 - 12/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 11/2019 - 10/2017
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2019 - 01/2019
2	RNA Splicing FactorsIBA 10/2019 - 12/2011
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 04/2017
2	Mitoxantrone (Novantrone)FDA LinkGeneric 12/2013 - 09/2009
2	purineIBA 12/2012 - 12/2002
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2009 - 01/2009
2	Methotrexate (Mexate)FDA LinkGeneric 11/2009 - 01/2009
2	Alemtuzumab (Campath)FDA Link 11/2008 - 02/2006
1	Serum AlbuminIBA 01/2022
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2022
1	Hexachlorobenzene (HCB)IBA 01/2022
1	tafasitamabIBA 12/2021
1	Lenalidomide (CC 5013)FDA Link 12/2021
1	CD19 AntigensIBA 12/2021
1	isatuximabIBA 11/2021
1	pomalidomideIBA 11/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 11/2021
1	cyclic adenosine-5'-trimetaphosphate (ATMP)IBA 10/2021
1	luspaterceptIBA 08/2021
1	crizanlizumabIBA 07/2021
1	Proteasome InhibitorsIBA 01/2021
1	obinutuzumabIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	belantamab mafodotinIBA 01/2021
1	acalabrutinibIBA 01/2021
1	venetoclaxIBA 12/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2020
1	A-Form DNA (A-DNA)IBA 11/2020
1	Oxygen (Dioxygen)IBA 01/2020

Therapy/Procedure

29	Therapeutics 01/2022 - 02/2002
7	Cell Transplantation 01/2021 - 01/2006
5	Immunotherapy 01/2022 - 09/2002
4	Stem Cell Transplantation 02/2022 - 01/2009
3	Transplantation 01/2012 - 02/2006
3	Drug Therapy (Chemotherapy) 07/2010 - 09/2009
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
2	Homologous Transplantation 11/2010 - 02/2006
2	Osteotomy 07/2006 - 09/2005
1	Intravenous Infusions 01/2021
1	Critical Care (Surgical Intensive Care) 01/2020